ClinicalTrials HQ

acquired partial lipodystrophy

acquired partial lipodystrophy

Explore linked clinical trials. Standard reference: MONDO:0012104
View definition

6 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin ResistanceInsulin Resistance, Nutritional and Metabolic Diseases, acquired partial lipodystrophy, glucose metabolism disease, hyperinsulinism, metabolic disease, partial lipodystrophyRecruitingPhase 22026-08-18NCT05470504
MEASuRE: Metreleptin Effectiveness And Safety RegistryCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, acquired partial lipodystrophy, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, metabolic disease, partial lipodystrophy, skin disorderRecruitingNot stated2026-07-16NCT02325674
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PLacquired partial lipodystrophy, partial lipodystrophyActive, not recruitingPhase 32026-06-15NCT05164341
Metabolic Phenotyping in vEDSAneurysm, Aortic Dissection, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dissection, Blood Vessel, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, vascular type, Hemic and Lymphatic Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, Skin Abnormalities, Skin and Connective Tissue Diseases, acquired partial lipodystrophy, cardiovascular disorder, connective tissue disorder, glucose metabolism disease, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, hyperinsulinism, metabolic disease, skin disorder, vascular disorder, vascular hemostatic diseaseRecruitingNot stated2026-04-08NCT07516496
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024acquired partial lipodystrophyRecruitingPhase 22025-09-09NCT07091734
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophyacquired partial lipodystrophy, partial lipodystrophyRecruitingPhase 42025-07-03NCT06484868